Carta al director
Respuesta a Idaptan® (trimetazidina): la panacea
Response to Idaptan® (trimetazidine): The panacea
Leído
5263
Vecesse ha leído el artículo
991
Total PDF
4272
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 7 | 4 | 11 |
| 2025 11 | 39 | 15 | 54 |
| 2025 10 | 38 | 3 | 41 |
| 2025 9 | 28 | 7 | 35 |
| 2025 8 | 15 | 8 | 23 |
| 2025 7 | 18 | 5 | 23 |
| 2025 6 | 19 | 7 | 26 |
| 2025 5 | 11 | 5 | 16 |
| 2025 4 | 16 | 2 | 18 |
| 2025 3 | 24 | 3 | 27 |
| 2025 2 | 23 | 2 | 25 |
| 2025 1 | 41 | 1 | 42 |
| 2024 12 | 21 | 3 | 24 |
| 2024 11 | 13 | 0 | 13 |
| 2024 10 | 9 | 2 | 11 |
| 2024 9 | 22 | 1 | 23 |
| 2024 8 | 26 | 3 | 29 |
| 2024 7 | 17 | 5 | 22 |
| 2024 6 | 21 | 6 | 27 |
| 2024 5 | 15 | 1 | 16 |
| 2024 4 | 22 | 4 | 26 |
| 2024 3 | 35 | 7 | 42 |
| 2024 2 | 31 | 4 | 35 |
| 2024 1 | 30 | 3 | 33 |
| 2023 12 | 35 | 8 | 43 |
| 2023 11 | 31 | 4 | 35 |
| 2023 10 | 54 | 6 | 60 |
| 2023 9 | 20 | 2 | 22 |
| 2023 8 | 18 | 5 | 23 |
| 2023 7 | 15 | 2 | 17 |
| 2023 6 | 28 | 1 | 29 |
| 2023 5 | 44 | 2 | 46 |
| 2023 4 | 44 | 1 | 45 |
| 2023 3 | 46 | 3 | 49 |
| 2023 2 | 22 | 1 | 23 |
| 2022 1 | 18 | 3 | 21 |
| 2022 12 | 13 | 4 | 17 |
| 2022 11 | 41 | 6 | 47 |
| 2022 10 | 21 | 6 | 27 |
| 2022 9 | 29 | 7 | 36 |
| 2022 8 | 31 | 8 | 39 |
| 2022 7 | 19 | 6 | 25 |
| 2022 6 | 14 | 5 | 19 |
| 2022 5 | 27 | 3 | 30 |
| 2022 4 | 26 | 7 | 33 |
| 2022 3 | 32 | 6 | 38 |
| 2022 2 | 31 | 4 | 35 |
| 2021 1 | 39 | 6 | 45 |
| 2021 12 | 36 | 9 | 45 |
| 2021 11 | 31 | 7 | 38 |
| 2021 10 | 27 | 10 | 37 |
| 2021 9 | 43 | 10 | 53 |
| 2021 8 | 29 | 5 | 34 |
| 2021 7 | 17 | 6 | 23 |
| 2021 6 | 30 | 6 | 36 |
| 2021 5 | 22 | 8 | 30 |
| 2021 4 | 41 | 11 | 52 |
| 2021 3 | 43 | 10 | 53 |
| 2021 2 | 30 | 6 | 36 |
| 2020 1 | 21 | 13 | 34 |
| 2020 12 | 20 | 5 | 25 |
| 2020 11 | 21 | 0 | 21 |
| 2020 10 | 10 | 7 | 17 |
| 2020 9 | 24 | 8 | 32 |
| 2020 8 | 27 | 8 | 35 |
| 2020 7 | 15 | 6 | 21 |
| 2020 6 | 14 | 10 | 24 |
| 2020 5 | 21 | 4 | 25 |
| 2020 4 | 8 | 4 | 12 |
| 2020 3 | 30 | 2 | 32 |
| 2020 2 | 19 | 1 | 20 |
| 2020 1 | 26 | 1 | 27 |
| 2019 12 | 71 | 8 | 79 |
| 2019 11 | 40 | 12 | 52 |
| 2019 10 | 21 | 7 | 28 |
| 2019 9 | 32 | 2 | 34 |
| 2019 8 | 12 | 8 | 20 |
| 2019 7 | 16 | 4 | 20 |
| 2019 6 | 38 | 11 | 49 |
| 2019 5 | 90 | 31 | 121 |
| 2019 4 | 41 | 48 | 89 |
| 2019 3 | 6 | 6 | 12 |
| 2019 2 | 15 | 9 | 24 |
| 2019 1 | 9 | 5 | 14 |
| 2018 12 | 14 | 12 | 26 |
| 2018 11 | 15 | 3 | 18 |
| 2018 10 | 21 | 11 | 32 |
| 2018 9 | 18 | 4 | 22 |
| 2018 8 | 5 | 4 | 9 |
| 2018 7 | 8 | 15 | 23 |
| 2018 6 | 2 | 4 | 6 |
| 2018 5 | 14 | 7 | 21 |
| 2018 4 | 3 | 4 | 7 |
| 2018 3 | 5 | 0 | 5 |
| 2018 2 | 19 | 5 | 24 |
| 2018 1 | 5 | 1 | 6 |
| 2017 12 | 5 | 2 | 7 |
| 2017 11 | 11 | 6 | 17 |
| 2017 10 | 8 | 4 | 12 |
| 2017 9 | 13 | 5 | 18 |
| 2017 8 | 32 | 9 | 41 |
| 2017 7 | 11 | 3 | 14 |
| 2017 6 | 16 | 4 | 20 |
| 2017 5 | 8 | 12 | 20 |
| 2017 4 | 9 | 7 | 16 |
| 2017 3 | 19 | 15 | 34 |
| 2017 2 | 18 | 5 | 23 |
| 2016 1 | 13 | 2 | 15 |
| 2016 12 | 25 | 6 | 31 |
| 2016 11 | 25 | 7 | 32 |
| 2016 10 | 37 | 15 | 52 |
| 2016 9 | 36 | 13 | 49 |
| 2016 8 | 27 | 5 | 32 |
| 2016 7 | 22 | 2 | 24 |
| 2016 6 | 25 | 17 | 42 |
| 2016 5 | 25 | 11 | 36 |
| 2016 4 | 24 | 9 | 33 |
| 2016 3 | 21 | 3 | 24 |
| 2016 2 | 17 | 7 | 24 |
| 2015 1 | 17 | 11 | 28 |
| 2015 12 | 22 | 11 | 33 |
| 2015 11 | 17 | 3 | 20 |
| 2015 10 | 25 | 8 | 33 |
| 2015 9 | 23 | 8 | 31 |
| 2015 8 | 14 | 2 | 16 |
| 2015 7 | 6 | 4 | 10 |
| 2015 6 | 14 | 6 | 20 |
| 2015 5 | 10 | 3 | 13 |
| 2015 4 | 16 | 8 | 24 |
| 2015 3 | 11 | 7 | 18 |
| 2015 2 | 19 | 1 | 20 |
| 2015 1 | 14 | 5 | 19 |
| 2014 12 | 36 | 7 | 43 |
| 2014 11 | 21 | 4 | 25 |
| 2014 10 | 34 | 3 | 37 |
| 2014 9 | 32 | 6 | 38 |
| 2014 8 | 21 | 12 | 33 |
| 2014 7 | 34 | 8 | 42 |
| 2014 6 | 31 | 6 | 37 |
| 2014 5 | 36 | 5 | 41 |
| 2014 4 | 37 | 7 | 44 |
| 2014 3 | 76 | 14 | 90 |
| 2014 2 | 867 | 78 | 945 |
| 2014 1 | 28 | 10 | 38 |
Mostrar todo
